Načítá se...
Testosterone therapy and prostate cancer
The use of exogenous testosterone to treat hypogonadism in the men with a history of prostate cancer (CaP) remains controversial due to fears of cancer recurrence or progression. Due to the detrimental impact of hypogonadism on patient quality of life, recent work has examined the safety of testoste...
Uloženo v:
| Vydáno v: | Transl Androl Urol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5182214/ https://ncbi.nlm.nih.gov/pubmed/28078223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.08.17 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|